HIV Medicine aims to provide an alternative outlet for publication of international research papers in the field of HIV medicine, embracing clinical, pharmacological, epidemiological, ethical, preclinical, and in vitro studies.

We focus on evidence-based medicine as the mainstay of successful management of HIV and AIDS. The journal is specifically aimed at researchers and clinicians with responsibility for treating HIV seropositive patients.

Online Publication from 2025

HIV Medicine will be published in online-only format effective with the 2025 volume. This is a proactive move towards reducing the environmental impact caused by the production and distribution of printed journal copies and will allow the journal to invest in further innovation, digital development, and sustainability measures.

Journal Metrics

  • 5.3CiteScore
  • 3.2Journal Impact Factor
  • 29%Acceptance rate
  • 21 days Submission to first decision
view all metrics

Articles

REVIEW ARTICLE

Aetiology of fever of unknown origin in people living with HIV: A systematic review and meta-analysis

Cesar Copaja-Corzo, Dayana Ticona-Tiña, Brenda Caira-Chuquineyra, Daniel Fernandez-Guzman, 
  •  21 July 2025
EDITORIAL

Editorial comment on: Gender equality in leadership of HIV care cascade clinical trials: A methodological study

Chloé Pasin, Chloe Orkin, 
  •  17 July 2025
SHORT COMMUNICATION

HIV prevention in London, UK, from 2017 to 2024: Outcomes, gaps and learnings

Gary Whitlock, Stephen Cole, Afshan Khurshid, Marta Boffito, Tara Suchak, the Dean Street Collaborative Group, 
  •  16 July 2025
EDITORIAL COMMENT

CROI 2025 BHIVA working group summary

Caroline A. Sabin, Tristan J. Barber, Laura Waters, Nicola Mackie, Clare van Halsema, Anna Maria Geretti, Iain Reeves, Laura Byrne, Yvonne Gilleece, 
  •  16 July 2025
LETTER TO THE EDITOR

Response to letter by Kumar et al. on “Exploring the cascade of mental health care among people with HIV experiencing depressive symptoms in the UK and Ireland: The POPPY study”

Hajra Okhai, Caroline A. Sabin, the POPPY Study Group, 
  •  16 July 2025
More articles

The following is a list of the most cited articles based on citations published in the last three years, according to CrossRef.

free access

Life expectancy of HIV-positive people after starting combination antiretroviral therapy: a meta-analysis

S Teeraananchai, SJ Kerr, J Amin, K Ruxrungtham, MG Law, 
  •  256-266
  •  31 August 2016
free access

Late presentation of HIV infection: a consensus definition

A Antinori, T Coenen, D Costagiola, N Dedes, M Ellefson, J Gatell, E Girardi, M Johnson, O Kirk, J Lundgren, A Mocroft, A D'Arminio Monforte, A Phillips, D Raben, JK Rockstroh, C Sabin, A Sönnerborg, F De Wolf, for the European Late Presenter Consensus working group, 
  •  61-64
  •  3 December 2010
Open access

Immune deficiency is a risk factor for severe COVID‐19 in people living with HIV

Christian Hoffmann, José L. Casado, Georg Härter, Pilar Vizcarra, Ana Moreno, Dario Cattaneo, Paola Meraviglia, Christoph D. Spinner, Farhad Schabaz, Stephan Grunwald, Cristina Gervasoni, 
  •  372-378
  •  27 December 2021
Open access

Sexualized drug use (‘chemsex’) and high-risk sexual behaviours in HIV-positive men who have sex with men

EL Pufall, M Kall, M Shahmanesh, A Nardone, R Gilson, V Delpech, H Ward, The Positive Voices study group, 
  •  261-270
  •  24 January 2018
free access

Rapid initiation of antiretroviral therapy at HIV diagnosis: definition, process, knowledge gaps

MA Boyd, M Boffito, A Castagna, V Estrada, 
  •  3-11
  •  6 February 2019
More articles

Latest news

More news >